Pediatric Allergic Rhinitis Treatment & Management

  • Author: Jack M Becker, MD; Chief Editor: Harumi Jyonouchi, MD   more...
 
Updated: Aug 12, 2011
 

Medical Care

Treatment of allergic rhinitis (AR) can be divided into 3 categories: avoidance of allergens or environmental controls, medications, and allergen-specific immunotherapy (allergy shots).

  • Use of environmental controls is not adequately explored in most patients. For many patients, the removal of the trigger can have a dramatic effect. Difficulty arises when the trigger needs to be identified and eliminated. Eliminating the trigger may be simple if removal of a feather pillow or blanket is involved; however, it can be very difficult if a family pet needs to be removed. Although avoiding outdoor pollens is impossible, the patient can reduce exposure to pollens to attenuate symptoms.
  • Identification and elimination is easiest for dust mite allergens.
    • Feathered bedding should be removed and replaced with a fiber-filled product encased by dust mite–proof encasings. Such encasings can be purchased at the local stores or via mail orders. These encasings should be zip-locked and cover all surface areas.
    • A bed pad that is placed on top is not helpful and may be another source of dust mite infestation.
    • Less expensive plastic encasings may leak allergens through needle holes or between zipper teeth; therefore, more expensive dust mite–proof covers are preferable.
    • The pillow must be covered; this is even more crucial than covering the bed mattress itself because the pillow is where the patient's head usually spends most of the night. Box springs usually do not need to be covered.
    • Care should be taken to be sure the encasings are dust mite–proof. Some products may claim to be an allergy cover but may not provide the proper protection for dust mite. Also hypoallergenic bedding usually refers to the fact that the bedding is not made of feathers and does not necessarily mean that it is dust mite–proof.
  • Pollen is more difficult to avoid because daily activities must be altered to do so.
    • The patient is best advised to remain indoors with air-conditioning during the period of the highest pollen counts of the day. Commonly, remaining indoors is not possible because of activities, and many schools are not air-conditioned.
    • An easy intervention is to keep the windows closed, which is easily accomplished in air-conditioned homes and must be done throughout the year. Windows tend to be opened most frequently during fall and spring in moderate climates, but these seasons are the worst possible times for open windows for patients with pollen allergy. If windows must be open, open them during the day and close them at night. Many pollen counts are highest during the night, especially for molds and trees.
    • Another intervention is to obtain a window filter or filter fan, which allows air, but not pollen, to enter the room.
    • Advise patients to wash head to toe and to change clothing upon coming in from the outdoors during high pollen season. Avoid hanging cloths outdoors to dry.
  • The most difficult trigger to avoid is the family pet. Ideally, the pet should be removed from the home, but removal is the option, not the rule. Some helpful manipulations include removing the pet from the patient's bedroom and play area, using air cleaners in these areas and, occasionally, frequently sponge-bathing the pet (once per week). Even when these interventions are performed, many patients continue to experience symptoms. Other therapies are necessary in these patients; however, some patients choose to live with the source of offending allergens.
  • See Medication for a discussion of medications and allergen-specific immunotherapy (ie, allergy shots). A recent study concluded that specific immunotherapy can be recommended for treatment because it is effective in reducing symptoms.[8]
Next

Surgical Care

  • No routine surgical care is needed.
  • Some patients may be seen by ear, nose, and throat (ENT) specialists, and turbinectomies may be performed to provide some relief. This is an extreme measure and is reserved for patients in whom all other therapies have failed.
  • Rarely, in adults, if nasal polyps do not respond to topical nasal steroids, surgical removal may be necessary, although the polyps often grow back.
Previous
Next

Consultations

  • Primary care physicians can attend to most patients.
  • Patients in whom diagnosis or treatment is more difficult may require consultation with a specialist. This usually starts with an allergist, who performs a complete allergy evaluation, including diagnostic tests. Therapy is instituted, which is a combination of environmental manipulations, medications and, in some patients, allergen-specific immunotherapy.
  • If medical therapies do not produce an adequate result, referral to an ENT specialist should be indicated for possible surgical intervention.
Previous
Next

Diet

  • Dietary restrictions do not help because allergic rhinitis is not triggered by foods.
Previous
Next

Activity

  • No limitations are placed on activity.
  • For some pollens, patients with allergic rhinitis benefit from avoiding the outdoors during peak pollen periods of the day. This time varies according to pollens and location. Geographic location and distance from the source have an impact. Patients who are miles away from the source have different peak pollen times than patients near the source.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Jack M Becker, MD  Clinical Associate Professor of Pediatrics, Drexel University School of Medicine

Jack M Becker, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, and American College of Allergy, Asthma and Immunology

Disclosure: gsk Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; AstraZenica Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; Ivax Honoraria Speaking and teaching

Specialty Editor Board

C Lucy Park  MD, Head, Division of Allergy, Immunology, and Pulmonology, Associate Professor, Department of Pediatrics, University of Illinois at Chicago College of Medicine

C Lucy Park is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Medical Association, Chicago Medical Society, Clinical Immunology Society, and Illinois State Medical Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

John Wilson Georgitis, MD  Consulting Staff, Lafayette Allergy Services

John Wilson Georgitis, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association for the Advancement of Science, American College of Chest Physicians, American Lung Association, American Medical Writers Association, and American Thoracic Society

Disclosure: Nothing to disclose.

David Pallares, MD  Clinical Assistant Professor, Department of Pediatrics, Division of Allergy and Immunology, University of Louisville School of Medicine

David Pallares, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology

Disclosure: Nothing to disclose.

Chief Editor

Harumi Jyonouchi, MD  Associate Professor, Division of Pulmonary, Allergy/Immunology, and Infectious Diseases, Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Harumi Jyonouchi, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American Association of Immunologists, American Medical Association, Clinical Immunology Society, New York Academy of Sciences, Society for Experimental Biology and Medicine, Society for Mucosal Immunology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

References
  1. Meltzer EO. Productivity costs of antihistamines in the workplace. Occup Health Saf. Aug 1996;65(8):46-50. [Medline].

  2. [Guideline] World Health Organization (WHO). Allergic rhinitis and its impact on asthma. 2008;[Full Text].

  3. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. Jan 2002;109(1):57-62. [Medline].

  4. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. Feb 17 2004;140(4):278-89. [Medline].

  5. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. Jan 1997;99(1 Pt 1):22-7. [Medline].

  6. Herr M, Clarisse B, Nikasinovic L, et al. Does allergic rhinitis exist in infancy? Findings from the PARIS birth cohort. Allergy. Feb 2011;66(2):214-21. [Medline].

  7. Söderström L, Lilja G, Borres MP, Nilsson C. An explorative study of low levels of allergen-specific IgE and clinical allergy symptoms during early childhood. Allergy. Aug 2011;66(8):1058-64. [Medline].

  8. [Best Evidence] Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol. Jan 2009;102(1):22-8. [Medline].

  9. Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. May 2006;117(5):1021-35. [Medline].

  10. Aaronson DW. Side effects of rhinitis medications. J Allergy Clin Immunol. Feb 1998;101(2 Pt 2):S379-82. [Medline].

  11. Allergies in America. Allergies in America Executive Summary. myallergiesinamerica. Available at http://www.myallergiesinamerica.com/pdfs/myaia.pdf. Accessed June 2007.

  12. Busse W. Allergic rhinitis: charting a course for the 21st century. J Respir Dis. 1998;19:S1-64.

  13. Day J. Pros and cons of the use of antihistamines in managing allergic rhinitis. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S395-9. [Medline].

  14. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. May 1998;101(5):638-45. [Medline].

  15. Delafuente JC, Davis TA, Davis JA. Pharmacotherapy of allergic rhinitis. Clin Pharm. Jul 1989;8(7):474-85. [Medline].

  16. Hemp P. Presenteeism: at work--but out of it. Harv Bus Rev. Oct 2004;82(10):49-58, 155. [Medline].

  17. Hussain I, Kline JN. DNA, the immune system, and atopic disease. J Investig Dermatol Symp Proc. Jan 2004;9(1):23-8. [Medline].

  18. LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S388-94. [Medline].

  19. [Best Evidence] Lange B, Lukat KF, Rettig K, Holtappels G, Bachert C. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. Sep 2005;95(3):272-82. [Medline].

  20. Ledford DK, Lockey RF. Allergic rhinitis: understanding the process. J Respir Dis. 1998;19(7):576-84.

  21. Middleton E, Reed C, Ellis E. Allergic and non-allergic rhinitis. In: Allergy: Principles and Practice. Vol 2. 5th ed. Mosby-Year Book; 1998:Chapter 70.

  22. Naclerio R, Solomon W. Rhinitis and inhalant allergens. JAMA. Dec 10 1997;278(22):1842-8. [Medline].

  23. Plevkova J, Brozmanova M, Pecova R, Tatar M. Effects of intranasal histamine on the cough reflex in subjects with allergic rhinitis. J Physiol Pharmacol. Sep 2005;56 Suppl 4:185-95. [Medline].

  24. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. Jan-Feb 1994;15(1):21-5. [Medline].

  25. Spector S. Pathophysiology and pharmacotherapy of allergic rhinitis. Foreword. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S377. [Medline].

  26. Sublett JL. The environment and risk factors for atopy. Curr Allergy Asthma Rep. Nov 2005;5(6):445-50. [Medline].

  27. [Best Evidence] Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol. Jan 2009;123(1):160-166.e3. [Medline].

  28. Wheeler PW, Wheeler SF. Vasomotor rhinitis. Am Fam Physician. Sep 15 2005;72(6):1057-62. [Medline].

Previous
Next
 
Photo demonstrates the allergic salute, which is the action performed when a patient rubs the nose using a motion across the nose.
Photo demonstrates allergic shiners. Note the periorbital edema and bluish discoloration seen in allergic rhinitis and sinusitis.
Impact of nasal allergies.
How patient feel when they have allergy symptoms.
Nasal symptoms and affect on work performance.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.